Alliance for Lupus Research and Lupus Research Institute are pleased to report the first milestone in the Accelerating Medicines Partnership (AMP) recently launched by the National Institutes of Health (NIH)to accelerate understanding of autoimmune diseases lupus and rheumatoid arthritis (RA). The NIH has awarded $6 million in grants to 11 research groups nationwide to establish the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Network. Over the next five years, the AMP RA/Lupus Network will analyze tissues and blood samples from patients with lupus or RA to generate a comprehensive understanding of both diseases and uncover new targets for drug development. Valuable insights into the mechanisms of autoimmune disease are also anticipated.
Posted on: Thu, 25 Sep 2014 14:05:15 +0000
Trending Topics
Recently Viewed Topics
© 2015